Factor VII 抗体
Quick Overview for Factor VII 抗体 (ABIN7673037)
抗原
See all Factor VII (F7) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- F7 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- coagulation factor VII(serum prothrombin conversion accelerator)
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:2000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
有效期
- 12 months
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
别名
- F7
-
背景
-
Synonyms: Coagulation factor VII|Proconvertin|Serum prothrombin conversion accelerator (SPCA)|Factor VII light chain|Factor VII heavy chain|F7
Background: Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
-
分子量
- 49-55 kDa
-
基因ID
- 2155
-
UniProt
- P08709
-
途径
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
抗原
-